Greg Krempl to Cetuximab
This is a "connection" page, showing publications Greg Krempl has written about Cetuximab.
Connection Strength
0.244
-
The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial. Cancer Res Commun. 2026 Mar 01; 6(3):706-713.
Score: 0.244
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.